Literature DB >> 6539408

A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture.

C M Taylor, B Blanchard, D T Zava.   

Abstract

Specific uptake of tritiated 17 beta-oestradiol and R5020, a synthetic progestin, in breast cancer cell lines ( MCF7 and T47D) growing in monolayer culture in multiwell plates has been shown. Binding characteristics, calculated by Scatchard analysis, indicate the presence of steroid receptors of similar affinities and capacities to those already obtained with broken cell preparations. Lysis of the cells by treatment with a hypotonic buffer reveals the subcellular localization of the receptors so the method can be used to study receptor dynamics such as nuclear translocation and processing. Cell growth can be measured by DNA determination directly in the multiwell plates. Thus, the method provides a convenient way of studying the effects of steroid hormones (or any antihormone or chemotherapeutic agent) on growth and receptor content of breast cancer cells in monolayer culture.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539408     DOI: 10.1016/0022-4731(84)90347-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  19 in total

1.  Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.

Authors:  R Poulin; D Baker; D Poirier; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Modeling the endocrine control of vitellogenin production in female rainbow trout.

Authors:  Kaitlin Sundling; Gheorghe Craciun; Irvin Schultz; Sharon Hook; James Nagler; Tim Cavileer; Joseph Verducci; Yushi Liu; Jonghan Kim; William Hayton
Journal:  Math Biosci Eng       Date:  2014-06       Impact factor: 2.080

3.  Inhibition of fibroblast proliferation in a culture of human endometrial stromal cells using a medium containing D-valine.

Authors:  M Frauli; H Ludwig
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

4.  Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells.

Authors:  W Roos; D Fabbro; W Küng; S D Costa; U Eppenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer.

Authors:  A Jarry; G Vallette; E Cassagnau; A Moreau; C Bou-Hanna; P Lemarre; E Letessier; J C Le Neel; J P Galmiche; C L Laboisse
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

6.  Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin.

Authors:  R Poulin; J M Dufour; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

7.  Collagen breakdown products and lung collagen metabolism: an in vitro study on fibroblast cultures.

Authors:  C Gardi; P Calzoni; P Marcolongo; E Cavarra; L Vanni; G Lungarella
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

8.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

9.  Effects of tamoxifen on human breast cancer cells in vitro.

Authors:  W E Simon; G Trams; F Hölzel
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

10.  Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells.

Authors:  J B Adams; R Vrahimis; N Phillips
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.